Eden Spine Granted US Patent on the WellDisc™ Lumbar Disc Prosthesis

Lake  Mary,  Florida  -­‐ Eden  Spine  (www.EdenSpine.com),a  technology  driven spinal  organization,  announced  today  that  the  United  States  Patent  and Trademark Office (USPTO)  has  granted  a  Patent  for  its  new  generation  Total Disc  Prosthesis,  the  WellDisc™.

“The  WellDisc™  is  a  step  forward  in  the  treatment  of  low  back  pain”  says Dr. Jean-­‐Philippe Lemaire, “as  it  controls  segmental  motion  and  restores the guiding function  of  the  facets while  decreasing  their  loading.  The result, based  on  my  20  years  of  experience  and  research in  the  arena, is  a prosthesis  that  is  unconstrained  in  the  neutral  zone,  constrained  outside  of the neutral  zone,  and respects  the  posterior elements of  the  segment; specifically  the  facet  joints.”

What  we  are  trying  to  obtain  added  Mourad  Ben  Mokhtar,  head  of  Eden Spine’s  R&D  efforts,  “is  to provide better long   term   results   for   patients,   making   clinical   results   more   predictable and successful.”

Eden  Spine’s  CEO,  Guillaume  Viallaneix,  commented  “The  granting  of  this Patent  protects  an  important  portion  of  Eden Spine  technology  assets  and furthers  differentiates  Eden  Spine  as  a  Research  &  Development  organization with  a  global  footprint.”

###

As a technology driven organization, Eden Spine LLC, a privately held spine company headquartered in Lake Mary, Florida, is positively impacting patient care and creating substantial value developing tomorrows’ spinal technologies and building a world class spine franchise, inclusive of a fiscally responsible sales & distribution network. The Eden Spine Group is commercially active in the United States, Europe, the Middle East and Latin America. The company possesses 5 proprietary technologies including three new-generation, motion preservation technologies; the WellDisc™ total disc replacement; the Perfx-2™ Dynamic Stabilization System, and the Wellex™ Interspinous Technology. Eden Spine currently distributes a range of FDA-cleared and CE Marked spine technologies in the US and internationally.

Contact Information:

Guillaume Viallaneix, CEO, Phone: 407-792-2279 – Fax: 407-264-8303

e-mail: G.Viallaneix@EdenSpine.com

US Headquarters: Eden Spine, LLC 801 International Parkway -5th Floor –Lake Mary, FL 32746 –

USA International: Eden Spine Europe SA Bd Helvetique, 36 -1207 Geneva -Switzerland

Web address: http://www.EdenSpine.com